Firebird Biomolecular Sciences

Firebird Biomolecular Sciences is a synthetic biology company that develops and commercializes artificially expanded genetic information systems. The company's core technology, AEGIS (Artificially Expanded Genetic Information System), adds new nucleotide letters to the natural DNA alphabet, enabling high-precision molecular recognition. This platform is utilized to improve the sensitivity and specificity of diagnostics for infectious diseases, including COVID-19 and HIV, as well as for liquid biopsy in oncology. Beyond diagnostics, Firebird provides specialized reagents and polymerases to the life sciences industry to support advanced genomic research. The company was founded by Dr. Steven Benner, a pioneer in the field of synthetic biology who first synthesized an artificial genetic system.